COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response Ali Farhoudian, Alexander Baldacchino, Nicolas Clark, Gilberto Gerra, Hamed Ekhtiari, Geert Dom, Azarakhsh Mokri, Mandana Sadeghi, Pardis Nematollahi, Maryanne Demasi, Christian G. Schütz, Seyed Mohammadreza Hashemian, Payam Tabarsi, Susanna Galea-singer, Giuseppe Carrà, Thomas Clausen, Christos Kouimtsidis, Serenella Tolomeo, Seyed Ramin Radfar, Emran Mohammad Razaghi An International Society of Addiction Medicine (ISAM) Practice and Policy Interest Group Position Paper 29 mars 2020 Abstract : Coronavirus disease 2019 (COVID-19) is escalating across the world with higher morbidities and mortalities in certain vulnerable populations. People who use drugs (PWUD) are a marginalized and stigmatized group with [...]
Lire la suiteShort- and Long-Term Effects of Cannabis on Headache and Migraine Carrie Cuttler, Alexander Spradlin, Michael J. Cleveland, and Rebecca M. Craft Journal of Pain, 2019. doi : 10.1016/j.jpain.2019.11.001 Highlights Headache and migraine ratings were reduced by nearly 50% after using cannabis Men reported larger reductions in headache after cannabis use than women Cannabis concentrates were related to larger reductions in headache than flower Evidence for tolerance to effects of cannabis on headache and migraine was detected Evidence for medication overuse headache was not detected Abstract Use of cannabis to alleviate headache and migraine is relatively common, yet research on its effectiveness remains sparse. We sought to [...]
Lire la suiteCannabis is Not a Suitable Human Coronavirus Treatment Marc Moulin March 20, 2020 https://www.rxleaf.com/cannabis-not-good-human-coronavirus-treatment/ Using cannabis as a human coronavirus treatment may make symptoms worse. Cannabis is great for a lot of things. For example, many physical conditions see symptom abatement with cannabinoid treatment. Additionally, there is adequate, and in some cases, strong, scientific evidence to support consuming cannabis for therapeutic relief. Unfortunately, fighting off influenza-like viruses is not one of them. It’s important to note that there is absolutely no evidence to suggest that cannabis is an effective human coronavirus treatment. On the contrary, researchers from Michigan State University provide recent evidence to demonstrate potentially harmful [...]
Lire la suiteAddiction au cannabis, confinement et détention Jean Michel Delile, David Saint Vincent, Laurent Michel, Patrick Veteau Fédération Addiction, mars 2020 Cannabis et dépendance Longtemps, beaucoup ont pensé que le cannabis n’était pas une drogue (dangereuse), ou alors seulement une drogue « douce », au sens où il n’entrainait pas de syndrome physique de manque, à la différence de l’alcool, des opiacés ou des benzodiazépines… Il a fallu beaucoup de temps aux usagers et aux médecins pour réaliser que l’évidence de la souffrance des patients démontrait que la clef de l’addiction en tant que trouble était plus dans le désir/besoin irrépressible de consommer que dans [...]
Lire la suiteImmune Responses Regulated by Cannabidiol James M. Nichols and Barbara L.F. Kaplan Cannabis and Cannabinoid Research, 2019, Volume X, Number X Doi : 10.1089/can.2018.0073 Abstract Introduction : Cannabidiol (CBD) as Epidiolex (GW Pharmaceuticals) was recently approved by the U.S. Food and Drug Administration (FDA) to treat rare forms of epilepsy in patients 2 years of age and older. Together with the increased societal acceptance of recreational cannabis and CBD oil for putative medical use in many states, the exposure to CBD is increasing, even though all of its biological effects are not understood. Once such example is the ability of CBD to be anti-inflammatory and [...]
Lire la suiteCannabis and Coronavirus : What Cannabis Patients Want to Know Jennifer Grant https://www.rxleaf.com/cannabis-and-coronavirus-what-cannabis-patients-want-to-know/ February 17, 2020 There is evidence that cannabis can reduce viral load in HIV, can it help COVID-19 patients? At the time of writing, there were 69, 287 confirmed cases of the coronavirus and 1670 deaths. With the rapid escalation of the outbreak, these numbers will surely be outdated by the time of publication. With several regions heading into states of emergencies, including quarantine, nervous travelers are looking for anti viral herbs to reduce the chance of infection. Patients have asked us: What about cannabis? There have been rumors about successful treatments for coronavirus, [...]
Lire la suiteWhere Is Marijuana Legal in the US? [2020] https://www.testclear.com/Where-Is-Marijuana-Legal-in-the-US-2020.aspx Marijuana continues to tread between legal and illegal status, depending on where you are looking in the US and for what purpose you are using the substance. Where Is Marijuana Legal? Medical Marijuana Recreational Marijuana Decriminalized THC-low, CBD-High Allowed Table of Contents Where Is Marijuana Legal? Where Is Marijuana Decriminalized? What Are State Marijuana Laws? What Is the Impact of Marijuana Legalization? What Is the Cole Memorandum? Is Marijuana Legal at the Federal Level? What’s Next for the Legalization of Marijuana? Where Does the Public Stand on Marijuana? What Can You Do? As far as the [...]
Lire la suiteAvec le confinement: beaucoup de syndromes de manque Benjamin ROLLAND https://www.addictolyon.fr/post/avec-le-confinement-beaucoup-de-syndromes-de-manque Addictolyon, 19/03/2020, Mis à jour : il y a 4 jours Avec le #confinement lié au #COVID19, les trafics de substances semblent s'être fortement réduits. Résultat: en ville, à l'hôpital, en prison, de nombreux syndromes de manque apparaissent. Afin de faciliter la reconnaissance et la prise en charge des syndrome de sevrage chez les patients, voici un petit document explicatif du repérage et du traitement des syndrome de sevrage à catégories importantes de substance: #tabac, #cannabis, et #opioïdes
Lire la suiteAbuse potential assessment of cannabidiol (CBD) in recreational polydrug users : A randomized, double-blind, controlled trial Kerri A. Schoedel, Isabella Szeto, Beatrice Setnik, Edward M. Sellers, Naama Levy-Cooperman, Catherine Mills, Tilden Etges, Kenneth Sommerville Epilepsy & Behavior, 2018, 88, 162–171. Doi : 10.1016/j.yebeh.2018.07.027 a b s t r a c t Rationale : Treatment with a highly purified oral solution of cannabidiol (CBD), derived from the plant Cannabis sativa L., demonstrated some evidence of central nervous system (CNS)-related adverse events in patients enrolled in phase 3 trials for treatment of childhood-onset epilepsy. Cannabidiol was categorized as a Schedule 1 substance by the United States Drug [...]
Lire la suiteIACM: Déclaration du Conseil sur la pandémie actuelle du corona virus et l'utilisation des cannabinoïdes IACM-Bulletin du 26 Mars 2020 Plusieurs études en laboratoire suggèrent que les cannabinoïdes peuvent avoir des effets antiviraux et antibactériens. Nous l’avons rapporté à plusieurs reprises dans le Bulletin de l'IACM. Cependant, il n'y a aucune preuve que des cannabinoïdes, tels que le CBD, le CBG ou le THC, ou encore des préparations de cannabis protègent contre l'infection du SRAS-CoV2 ou pourraient être utilisés pour traiter le Covid-19, la maladie produite par ce virus. Par ailleurs, rien ne prouve que l'utilisation de cannabinoïdes puisse augmenter le risque d'infection [...]
Lire la suite